ENDOGENOUS OPIOID PEPTIDES: REVIEW OF PHYSIOLOGICAL, PHARMACOLOGICAL AND CLINICAL ASPECTSFREDERICKSON RCA; GEARY LE.1982; PROGRESS IN NEUROBIOLOGY; ISSN 0301-0082; GBR; DA. 1982; VOL. 19; NO 1-2; PP. 19-69; BIBL. 13 P.Article

TRANSIENT APNEA AFTER AN ENKEPHALIN ANALOGUE IN THE PRETERM RABBITHEDNER T; HEDNER J; BERGMAN B et al.1981; BIOL. NEONATE; ISSN 0006-3126; CHE; DA. 1981; VOL. 39; NO 5-6; PP. 290-294; BIBL. 13 REF.Article

EFFECT OF A METHIONINE-ENKEPHALIN ANALOG IN HUNTINGTON'S DISEASEAGID Y; DESTEE A; LALLEMAND A et al.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 299-304; BIBL. 21 REF.Article

Synthetic enkephalin analog in the treatment of cancer chemotherapy-induced vomitingLISSONI, P; BARNI, S; CRISPINO, S et al.Cancer treatment reports. 1987, Vol 71, Num 6, pp 665-666, issn 0361-5960Article

The effectof D-ala-2-ME-PHE-4-MET-(O)-OL enkephalin on blood pressure, heart rate and digoxin-induced arrhythmias in the guinea pigRABKIN, S. w.Life sciences (1973). 1987, Vol 41, Num 9, pp 1109-1116, issn 0024-3205Article

Evidence for altered opioid activity in patients with cancerLISSONI, P; BARNI, S; PAOLOROSSI, F et al.British journal of cancer. 1987, Vol 56, Num 6, pp 834-837, issn 0007-0920Article

D-Ala-2-Me-Phe-4-Met(O)-ol-enkephalin in the nucleus tractus solitarius of the rat produces cardiorespiratory depressionRABKIN, S. W.General pharmacology. 1991, Vol 22, Num 3, pp 479-484, issn 0306-3623, 6 p.Article

Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [¹²⁵I]FK33824ROTHMAN, R. B; JACOBSON, A. E; RICE, K. C et al.Peptides (New York, NY. 1980). 1987, Vol 8, Num 6, pp 1015-1021, issn 0196-9781Article

DOSE-RELATED EFFECTS OF THE SYNTHETIC MET-ENKEPHALIN ANALOGUE FK 33-824 ON ESOPHAGEAL MOTOR ACTIVITY IN HEALTHY HUMANSSTACHER G; BAUER P; STEINRINGER H et al.1982; GASTROENTEROLOGY; ISSN 0016-5085; USA; DA. 1982; VOL. 83; NO 5; PP. 1057-1061; BIBL. 15 REF.Article

PLASMA PITUITARY HORMONE RESPONSES TO THE SYNTHETIC ENKEPHALIN ANALOG (FK 33-824) IN NORMAL SUBJECTS AND PATIENTS WITH PITUITARY DISEASESDEMURA R; SUDA T; WAKABAYASHI I et al.1981; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1981; VOL. 52; NO 2; PP. 263-266; BIBL. 14 REF.Article

INHIBITORY ACTION OF A MET-ENKEPHALIN ON ACTH RELEASE IN MANDEL POZO E; MARTIN PEREZ J; STADELMANN A et al.1980; J. CLIN. INVEST.; USA; DA. 1980; VOL. 65; NO 6; PP. 1531-1534; BIBL. 18 REF.Article

Met-enkephalin and the enkephalin analogue FK-33824 centrally inhibit adrenocorticotrophic hormone secretion in sheepXIAOMING WANG; TRESHAM, J. J; SLOGGINS, B. A et al.Clinical and experimental pharmacology and physiology. 1988, Vol 15, Num 11, pp 865-873, issn 0305-1870Article

FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushings diseaseALLOLIO, B; DEUSS, U; KAULEN, D et al.The Journal of clinical endocrinology and metabolism. 1986, Vol 63, Num 6, pp 1427-1431, issn 0021-972XArticle

Cardiorespiratory response to D-ala-2-Me-Phe-4-Met-(O)-ol-enkephalin after administration into the fourth cerebral ventricle of the rat : interaction with cholinergic mechanismsRABKIN, S. W.Pharmacology. 1991, Vol 42, Num 2, pp 68-78, issn 0031-7012, 11 p.Article